ATE164884T1 - Neue sieben-transmembran-rezeptor v28 - Google Patents

Neue sieben-transmembran-rezeptor v28

Info

Publication number
ATE164884T1
ATE164884T1 AT94903271T AT94903271T ATE164884T1 AT E164884 T1 ATE164884 T1 AT E164884T1 AT 94903271 T AT94903271 T AT 94903271T AT 94903271 T AT94903271 T AT 94903271T AT E164884 T1 ATE164884 T1 AT E164884T1
Authority
AT
Austria
Prior art keywords
new
transmembrane receptor
disclosed
receptors
transmembrane receptors
Prior art date
Application number
AT94903271T
Other languages
English (en)
Inventor
Ronald Godiska
Patrick W Gray
Vicki Louise Schweickart
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25525137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE164884(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icos Corp filed Critical Icos Corp
Application granted granted Critical
Publication of ATE164884T1 publication Critical patent/ATE164884T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Laminated Bodies (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT94903271T 1992-11-17 1993-11-17 Neue sieben-transmembran-rezeptor v28 ATE164884T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97745292A 1992-11-17 1992-11-17

Publications (1)

Publication Number Publication Date
ATE164884T1 true ATE164884T1 (de) 1998-04-15

Family

ID=25525137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903271T ATE164884T1 (de) 1992-11-17 1993-11-17 Neue sieben-transmembran-rezeptor v28

Country Status (9)

Country Link
US (2) US5759804A (de)
EP (2) EP0630405B1 (de)
JP (5) JPH07503145A (de)
AT (1) ATE164884T1 (de)
CA (1) CA2128208C (de)
DE (1) DE69317883T2 (de)
DK (1) DK0630405T3 (de)
ES (1) ES2118372T3 (de)
WO (1) WO1994012635A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017585A1 (en) 1991-04-05 1992-10-15 The Trustees Of Columbia University In The City Of New York Odorant receptors ans uses thereof
ES2118372T3 (es) 1992-11-17 1998-09-16 Icos Corp Nuevos receptores siete transmembrana v28.
US6107475A (en) * 1992-11-17 2000-08-22 Icos Corporation Seven transmembrane receptors
AU5325694A (en) * 1992-11-25 1994-06-22 Brigham And Women's Hospital Epstein barr virus induced genes
US5545549A (en) * 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US6537764B1 (en) 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
JPH11507513A (ja) * 1995-06-05 1999-07-06 インサイト・ファーマスーティカルズ・インコーポレイテッド Ｃ５ａ様７膜貫通受容体
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US5686597A (en) * 1995-06-06 1997-11-11 Incyte Pharmaceuticals, Inc. Thrombin receptor homolog
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
AU7011896A (en) * 1995-08-29 1997-03-19 Chiron Corporation Human hypothalmic ("hr") receptor polypeptide compositions, methods and uses thereof
WO1997045543A2 (en) 1996-05-28 1997-12-04 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health Cc chemokine receptor 5, antibodies thereto, transgenic animals
US6140064A (en) 1996-09-10 2000-10-31 Theodor-Kocher Institute Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
EP1995318A1 (de) 1996-12-13 2008-11-26 Schering Corporation Säugerzelloberflächenantigene und damit zusammenhängende Reagenzien
US6737252B2 (en) 1997-07-25 2004-05-18 Schering Corporation 7 transmembrane receptor family member BLRX
US5874252A (en) * 1997-07-29 1999-02-23 Smithkline Beecham Corporation Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
FR2771423A1 (fr) * 1997-11-21 1999-05-28 Transgene Sa Vecteurs permettant d'inhiber ou retarder la liaison d'un virus d'immunodeficience et/ou sa penetration dans une cellule cible
WO1999033976A1 (en) 1997-12-24 1999-07-08 Takeda Chemical Industries, Ltd. Polypeptide, their production and use
US6153441A (en) * 1998-02-17 2000-11-28 Smithkline Beecham Corporation Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof
CA2322731A1 (en) * 1998-03-04 1999-09-10 Icos Corporation Lectomedin materials and methods
WO2000000515A2 (en) 1998-06-29 2000-01-06 Hyseq, Inc. A CHEMOKINE RECEPTOR OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
JP2002531057A (ja) * 1998-08-19 2002-09-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｅｄｇ受容体ファミリーに関連したｇタンパク質結合受容体である１４２７４受容体
AU774850B2 (en) * 1999-01-04 2004-07-08 Lexicon Pharmaceuticals, Inc. Human seven-transmembrane receptors
WO2000068250A1 (en) * 1999-05-12 2000-11-16 Smithkline Beecham Corporation 7tm receptor rat apj
EP1194551A1 (de) * 1999-07-13 2002-04-10 MERCK PATENT GmbH An ein g-protein gekoppelter rezeptor und dazugehörige dns
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
AU2000273378A1 (en) * 2000-02-18 2001-08-27 Millennium Pharmaceuticals, Inc. Therapeutic methods that target fractalkine or cx3cr1
EP1265925A2 (de) * 2000-02-23 2002-12-18 PHARMACIA & UPJOHN COMPANY G protein-gekoppelte rezeptoren
WO2001070815A1 (fr) * 2000-03-21 2001-09-27 Yamanouchi Pharmaceutical Co., Ltd. Nouveau recepteur du leucotriene b4
AU2001242749A1 (en) * 2000-03-23 2001-10-03 Takeda Chemical Industries Ltd. Peptide derivative
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
CA2487438A1 (en) * 2002-06-10 2003-12-18 Metabolex, Inc. Methods of treating and diagnosing diabetes with cx3cr1 modulators
US7271209B2 (en) * 2002-08-12 2007-09-18 Exxonmobil Chemical Patents Inc. Fibers and nonwovens from plasticized polyolefin compositions
IL152824A (en) * 2002-11-13 2012-05-31 Mosaid Technologies Inc A socket that can be connected to and the network that uses it
WO2004106938A2 (en) * 2003-06-02 2004-12-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7)
WO2005040829A2 (en) * 2003-10-21 2005-05-06 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 17 (gpr17)
WO2005105841A2 (en) 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
EP1741792B1 (de) 2004-04-27 2010-11-03 Takeda Pharmaceutical Company Limited Neuer ligand eines g-protein-konjugierten rezeptorproteins und verwendung davon
ITMI20042007A1 (it) * 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
EP1996619A4 (de) * 2006-02-14 2009-11-18 Geisinger Clinic Gpcrs als angiogenese-targets
US20100215663A1 (en) * 2006-02-15 2010-08-26 Northwestern University Methods and compositions for regulation of neurological conditions
JP5509709B2 (ja) 2009-07-24 2014-06-04 日清紡ケミカル株式会社 燃料電池セパレータ
US8921307B2 (en) 2012-11-20 2014-12-30 Novartis Ag Synthetic linear apelin mimetics for the treatment of heart failure
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
WO2015013168A1 (en) 2013-07-25 2015-01-29 Novartis Ag Cyclic polypeptides for the treatment of heart failure
US9340582B2 (en) 2013-07-25 2016-05-17 Novartis Ag Bioconjugates of synthetic apelin polypeptides
PT3345618T (pt) * 2015-09-03 2022-02-02 Ono Pharmaceutical Co Agente para aumentar a imunidade ao cancro usando o antagonista da alergina-1
JOP20190187A1 (ar) 2017-02-03 2019-08-01 Novartis Ag مترافقات عقار جسم مضاد لـ ccr7

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149772T5 (es) * 1991-03-29 2008-02-16 Genentech, Inc. Receptores humanos pf4a y su utilizacion.
EP0579739A4 (de) * 1991-04-10 1994-03-22 Univ Boston Interleukin-8-rezeptoren, damit in zusammenhang stehende moleküle und verfahrensweisen.
ES2118372T3 (es) 1992-11-17 1998-09-16 Icos Corp Nuevos receptores siete transmembrana v28.

Also Published As

Publication number Publication date
US6348574B1 (en) 2002-02-19
JP2000350582A (ja) 2000-12-19
WO1994012635A2 (en) 1994-06-09
DE69317883T2 (de) 1998-11-12
EP0846762A2 (de) 1998-06-10
US5759804A (en) 1998-06-02
ES2118372T3 (es) 1998-09-16
EP0630405A1 (de) 1994-12-28
CA2128208A1 (en) 1994-06-09
DE69317883D1 (de) 1998-05-14
JP2004000268A (ja) 2004-01-08
DK0630405T3 (da) 1999-01-04
EP0846762A3 (de) 1998-09-23
JP2006129879A (ja) 2006-05-25
CA2128208C (en) 2004-01-06
WO1994012635A3 (en) 1994-10-13
JP2004298202A (ja) 2004-10-28
EP0630405B1 (de) 1998-04-08
JPH07503145A (ja) 1995-04-06

Similar Documents

Publication Publication Date Title
ATE164884T1 (de) Neue sieben-transmembran-rezeptor v28
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
EP1028315A3 (de) Zielspezifische Screens und ihre Verwendung zur Ermittelung von kleinen organischen molekularen Pharmakophoren
DE69034269D1 (de) Neues Verfahren zur Erschliessung des immunologischen Repertoirs
HUS1400027I1 (hu) OBM elleni antitestek
DK0673420T3 (da) Mammale receptorer for interleukin 10 (IL-10)
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
ES2090211T3 (es) Ensayos de fijacion a receptores, exentos de celulas, su produccion y utilizacion.
ATE150871T1 (de) Verfahren zur herstellung von biologisch aktiven reagentien aus succinimid enthaltenden polymeren, analytisches element und verwendungsmethoden
TW200716746A (en) Methods for identifying a compound modulating the binding between polypeptides
AU1527188A (en) Factor viii binding domain of von willebrand factor
ES2062394T3 (es) Medio que contiene un ligando para la separacion cromatografica, procedimiento para la preparacion del medio y uso del medio para aislar moleculas naturales o sinteticas de una mezcla liquida.
EP0574414A4 (de) Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert.
DE60228082D1 (de) Nten und neue liganden und pharmazeutische zusammensetzungen
ATE224448T1 (de) Icam-4 material und verfahren
DE68906758D1 (de) Immunoadsorbens mit geringer freisetzungsrate und verfahren zu seiner herstellung.